China: GSK puts China corruption case behind it, forms new business model
GlaxoSmithKline emerged from its corruption scandal in China in 2013 to form a new business model in the country and is committed to further expansion there, chief executive officer Andrew Witty told China Daily in London on Wednesday in an exclusive interview.
“We think it’s a very sad and disappointing experience, but we’ve reacted constructively and learnt many things. And now we understand China better, we have a new commercial model and incentive system, which is in step with the expectations of the Chinese government,” Witty said.
In 2013, GSK was found by the Chinese authorities to be bribing doctors to prescribe its drugs to patients, and after a court trial the company was made to pay a $489 million fine in 2014.
The original article can be found at www.chinadaily.com.cn
1 Comment
business analytics
November 19, 2015 at 11:54 pmIn nearly every situation, the price of your BI program can be a
major aspect, and also can probably maximum the bing search to unique segments of the marketplace.
Your without a girlfriend the vast majority
of important element of cost, on the other hand, will be to make certain you fully grasp your true total
cost of ownership (TCO) of your solutions you will be considering.
In typical BI achievements, the expense of the program is a small fraction of everything have to cover.
For the reason that the vast majority of BI possibilities require expensive integration and additionally report production professional services.
The expense of our asking services practically always eclipse the
program certification commissions. Furthermore, the required services needs to manage your data and additionally analytic applications (e.g., editing and
extending them to fulfill your changing requires of your
business users) and additionally create brand-new ones also need
to be studied right into consideration. You may make the assumption that an individual will constantly
require more of the professional services versus an individual expect.